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According to new published data, HIV/AIDS infection
currently knows an increase of 8% for the countries of
Eastern Europe and Central Asia. This happened in our
country too, where a new way to get started HIV
appeared: intravenous drugs used of so-called soft, legal
drugs (ethnobotanicals) near the classic heroin. Objectives:
To study the impact of HIV infection and the trend in
mortality in a cohort of 497 newly diagnosed patients
enrolled between 01.01.2011 and 31.12.2013 in the Clinical
Hospital of Infectious and Tropical Diseases “Dr. Victor
Babeş”, Department Casa Andreea, Bucharest. These new
cases were intravenous drug users (IVDUs) but also late
and very late presenters sexually infected and nonIVDUs.
We performed a retrospective study of patients newly
diagnosed with HIV infection that died during the 36
analyzed months. The research was based on clinical
records and autopsy reports. Patients lost from follow up
or died at home were excluded.
Our cohort enrolled 497 patients: 249 IVDUs and 248
nonIVDUs. Men were in greater proportion, dominated
the IVDU group. The average patient age was 30.8 years
old, similar age for both genders. Sixty-eight (13.65%)
patients died. 27 IVDU and 41 nonIVDU (total deaths
were 106 - 20.1% those diagnosed before 2011 but who
died in the analyzed period were excluded). Most deaths
were recorded in IVDU in 2012, and in nonIVDU in 2011.
Mean CD4 cell count was 126.62 lymphocytes/cmm in
IVDU and 75.75/cmm in nonIVDU. IVDUs were classified
in approximately equal proportions in C3/B3 class and
the other category in class C3. HCV co infection was
present in all IVDU and only in 7.31% of nonIVDUs.
IVDUs causes of death in descending order were MSSA
sepsis and tricuspid endocarditis (in 2013 began appear-
ing MRSA) followed by pulmonary and disseminated
tuberculosis (TB), HCV decompensated cirrhosis and
drugs overdoses. In nonIVDUs, opportunistic infections
were causes of death (toxoplasmosis, PCP, neglected TB
treatment, lymphoma). Death occurred at a mean of
14.5 weeks (limit 3 days-104 weeks) for nonIVDU and
17.7 weeks for the IVDU weeks (range: 1 day- 93 weeks)
for IVDUs.
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